Clinical Trial to Compare the Pharmacokinetics and Safety of Eperisone HCl SR Tablet 75mg and Myonal Tablet 50mg

NVP Healthcare27 enrolled

Overview

The purpose of this study is to Evaluate and Compare Safety and Pharmacokinetic of the Eperisone HCl SR and Myonal in healthy Korean male adults.

Myonal: Eperisone Hydrochloride (muscle relaxant)

Study Type

OBSERVATIONAL

Enrollment

Conditions

Low Back Pain

Eligibility

Sex: MALEMin age: 20 YearsMax age: 55 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy male subjects age between 20 and 55 singed informed consent Exclusion Criteria: * Hypotension or hypertension has a history of allergy reaction of this drug or other drugs

Locations (1)

Gyeonggi SMB Growth Accelerating Center

Suwon, Gyeonggi-do, South Korea

Outcomes

Primary Outcomes

Auclast, Cmax

Time frame: Eperisone SR 0-24h, Myonal 0-24hr

Secondary Outcomes

AUCinf, Tmax, t1/2, Css,min, Tss,max

Time frame: Eperisone SR 0-24hr, Myonal 0-24hr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.